Tango Therapeutics (TNGX) Current Leases (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly Current Leases of $2.8 million for Q1 2026, little changed year-over-year from $2.8 million in Q1 2025, and up 3.43% quarter-over-quarter from $2.7 million in Q4 2025.
Tango Therapeutics (TNGX) Current Leases (2020 - 2026) Analysis & Trends
Tango Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Current Leases changed 0.28% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (changed 0.28% YoY), while the FY2025 annual figure was $2.7 million, up 11.57% from the prior year.
- Current Leases for Q1 2026 stood at $2.8 million, up from $2.7 million in the prior quarter.
- The five-year high for Current Leases was $3.1 million in Q3 2025, with the low at $629000.0 in Q2 2022.
- The 5-year median for Current Leases is $2.4 million (2024), against an average of $2.2 million.
- The sharpest annual moves came in 2022 and 2023: Current Leases fell 28.48% in 2022, then jumped 187.28% in 2023.
- Tango Therapeutics' Current Leases stood at $1.8 million in 2022, then gained by 17.63% to $2.1 million in 2023, then climbed by 17.87% to $2.5 million in 2024, then gained by 11.57% to $2.7 million in 2025, then gained by 3.43% to $2.8 million in 2026.
- Business Quant data shows TNGX's Current Leases at $2.8 million in Q1 2026, $2.7 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - | 2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.94 Mn |
| Mar 31, 2026 | 2.83 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | 2.82 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 2.36 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 2.64 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 781,000.00 |
| Jun 30, 2022 | 629,000.00 |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 1.50 Mn |
| Sep 30, 2021 | 1.09 Mn |